National Resilience
Overview
Technology-driven biomanufacturing for complex medicines and therapies.
Founded
2020
Deals · 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Dionymer | Dec 2023Led | $2 MOther Equity | |
OKO | Dec 2021Participated | $1 MSeed | |
Cellevolve Bio | Nov 2021Participated | $6 MSeed | |
bit.bio | Nov 2021Participated | $103 MSeries B | |
Garuda Therapeutics | Sep 2021Participated | $72 MSeries A | |
OKO | Apr 2021Led | $1 MSeed | |
Dionymer | Dec 2023Led | $2 MOther Equity | |
OKO | Dec 2021Participated | $1 MSeed | |
Cellevolve Bio | Nov 2021Participated | $6 MSeed | |
bit.bio | Nov 2021Participated | $103 MSeries B | |
Garuda Therapeutics | Sep 2021Participated | $72 MSeries A | |
OKO | Apr 2021Led | $1 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 2 |
| Series A | 0 | 1 |
| Series B | 0 | 1 |
| Other Equity | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 2 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Networks, Cloud & Communication | 2 |
| Fintech | 1 |
| Enterprise Software | 1 |
| Food & Agriculture | 1 |
| Professional Services | 1 |
| Clean Energy & Sustainability | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 1 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 1 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 3 |
| Europe | 2 |
| Mali | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| ImpactAssets | 2 |
| Mercy Corps Ventures | 2 |
| Newfund | 2 |
| RaSa | 2 |
| Techstars | 2 |
| AFI Ventures | 1 |
| Aisling Capital | 1 |
| Aquiti Gestion | 1 |
| ARCH Venture Partners | 1 |
| Boxcar PMJ | 1 |
| Catalytic Impact Foundation | 1 |
| Charles River Laboratories | 1 |
| Cormorant Asset Management | 1 |
| Foresite Capital | 1 |
| IRDI Capital Investissement | 1 |
| Mass General Brigham Ventures | 1 |
| Metaplanet | 1 |
| Monashee Investment Management | 1 |
| Northpond Ventures | 1 |
| OrbiMed | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 33% |
| Participating | 4 | 67% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 2 | 100% |
Team
Head of Research Operations
Directeur industriel
Vice President Of Engineering
Chief Quality Officer
Sr. Manager, Talent Acquisition Operations
Head of Government Affairs and AI Strategy
Senior Director of Software Engineering
Process Engineer III, Equipment Engineering